ARUVANT
Aruvant Sciences is a clinical-stage biopharmaceutical company committed to developing and commercializing transformative gene therapies for rare diseases. It is focused on developing and commercializing gene therapies for hematological diseases utilizing reduced-intensity conditioning.
ARUVANT
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-11-26
Address:
Millburn, New Jersey, United States
Country:
United States
Website Url:
http://www.aruvant.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location YouTube Google Cloud Iowa
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Roche Diagnostics
Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.
Official Site Inspections
http://www.aruvant.com
- Host name: 172.65.190.172
- IP address: 172.65.190.172
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aruvant"
Aruvant - Crunchbase Company Profile & Funding
Aruvant Sciences is a clinical-stage biopharmaceutical company committed to developing and commercializing transformative gene therapies for rare …See details»
12BET-Sports Betting Winners
「信誉官网」12bet是提供了大量的创业金点子,12bet推出了自主研发的平台，是历史上最成功的娱乐操作系统之一,12bet有丰富的成名路线，构建你心中的天空之城,在线从其试运营第一天的几 …See details»
Aruvant - LinkedIn
Aruvant is a part of the Roivant family of companies. We have a talented team with extensive experience in the development, manufacturing and commercialization of gene therapy products.See details»
Aruvant Sciences Company Profile | Management and Employees …
Aruvant has an active research program with a lead product can didate, ARU-1801, in development for individuals suffering from SCD. ARU-1801, an investigational lentiviral gene …See details»
Aruvant Company Profile - Office Locations, Competitors ... - Craft
Aruvant Summary. Company Summary. Overview. Aruvant Sciences is a company that develops and commercializes gene therapies for hematological diseases. It prodives ARU-1801, a drug …See details»
Aruvant Sciences, Inc. - Drug pipelines, Patents, Clinical trials
May 8, 2025 Explore Aruvant Sciences, Inc. with its drug pipeline, therapeutic area, technology platform, 23 news, Disease Domain:Endocrinology and Metabolic Disease, Technology …See details»
Aruvant - 2025 Company Profile & Competitors - Tracxn
Apr 3, 2025 Aruvant is an unfunded company based in Basel (Switzerland), founded in 2018. It operates as a Developer of therapies to treat rare diseases. Aruvant has not raised any …See details»
Aruvant Sciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aruvant Sciences, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Aruvant - VentureRadar
Aruvant Sciences, part of the Roivant family of companies, is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies for the treatment of rare …See details»
ARUVANT SCIENCES HOLDINGS LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARUVANT SCIENCES HOLDINGS LTD. of LONDON. Get the latest business insights from Dun & …See details»
Roivant Launches Aruvant Sciences and Roivant Foundation in …
Nov 26, 2018 In addition to establishing Aruvant, Roivant has created a nonprofit organization, the Roivant Foundation, focused on improving access to therapies for sickle cell disease for …See details»
Aruvant - Crunchbase
Aruvant is focused on developing and commercializing gene therapies for hematological diseases utilizing reduced-intensity conditioning. Search Crunchbase. Start Free Trial . Chrome …See details»
Aruvant Announces Oral Presentation at American Society of Gene …
May 16, 2022 MILLBURN, N.J. and BASEL, Switzerland, May 16, 2022 (GLOBE NEWSWIRE) -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for …See details»
Aruvant Chooses Lonza to Manufacture ARU-1801, a Potentially …
Jan 18, 2021 Aruvant has chosen Lonza to help develop and manufacture ARU-1801 for its upcoming pivotal trial. ... The company has expanded the internal technical and operational …See details»
Ramaswamy's latest 'vant' to focus on gene therapies for blood ...
Nov 26, 2018 Punam Malik, M.D., director of the Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children's, developed Aruvant’s lead candidate, known as RVT-1801. The gene …See details»
Aruvant Sciences - Nature
Aruvant Sciences is a private clinical-stage gene therapy company focused on developing and commercializing transformative therapies for patients with severe hematological conditions. …See details»
Inside Aruvant's Gene Therapy Manufacturing Strategy
Oct 7, 2021 His organization spends the bulk of its time and expertise helping biopharma companies make manufacturing decisions, chief among them whether to lay out the capital …See details»
ARU-2801 - Drug Targets, Indications, Patents - Synapse
NEW YORK and BASEL, Switzerland, Sept. 20, 2021 /PRNewswire/ -- Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced …See details»
Aruvant Chooses Lonza to Manufacture ARU-1801, a Potentially …
Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant’s one-time …See details»
Aruvant chooses Lonza to Manufacture ARU-1801, a Potentially …
Jan 18, 2021 Aruvant is building a hybrid supply model that is led by the company's cell and gene therapy scientists and leverages specialized external suppliers. The company has …See details»